SINDROMUL METABOLIC CA REFLECTARE A DISSANOGENIEI INTERRELAŢIILOR PSIHOSOMATICE

Vlada FURDUI, Ana LEORDA, Viorica GUGLEA, Anastasia TELEVCO, Tatiana BEŞETEA

Abstract


Sindromul metabolic reprezintă un efect advers al stilului de viață simpato-adrenal și stresogen al omului contem­po­ran, care afectează 15-25% din populația globală. Modificările în sfera psihică la persoanele cu sindrom metabolic includ instabilitatea emoţională, tulburări cognitive, stări depresive, anxietate şi ipohondrie, iar manifestările somatice – obezitatea abdominală, precum și creșterea tensiunii arteriale, a conținutului glucozei și a unor indici ai colesterolului în sânge. Tulburările cognitive şi emoţionale, cauzate de rezistenţa la insulină, nu au legătură cu vârsta persoanei cu sindrom metabolic, dar depind de durata afecţiunii. Între severitatea manifestărilor somatice şi psihice ale sindromului metabolic şi nivelul neuromediatorilor excitatori există o corelaţie directă, iar cu nivelul neuromediatorilor inhibitori – o corelaţie inversă.

 

METABOLIC SYNDROME AS REFLECTING DYSANOGENICITY OF

PSYCHOSOMATIC INTERRELATIONS

Metabolic syndrome is an adverse effect of sympathoadrenal and stressogenic lifestyle. Changes in the psychological sphere in people with metabolic syndrome include emotional instability, cognitive disorders, depressive states, anxiety, and hypochondria, and somatic manifestations - abdominal obesity, and increased blood pressure, glucose and indices of cholesterol in the blood. Cognitive and emotional disorders, caused by insulin resistance are unrelated to the age of the person with metabolic syndrome, but depends on disease duration. Between the severity of somatic and psychic manifestations of metabolic syndrome and the level of excitatory neuromediators there is a direct correlation, and with the level of inhibitory neuromediators it is a reverse correlation.


Keywords


metabolic syndrome, cognitive and emotional disorders, insulin resistance, abdominal obesity, hypertension, changes in amino acid content

Full Text:

PDF

References


WATSON, G.S., PESKIND, E.R., ASTHANA, S. et al. Insulin increases CSF Abeta42 levels in normal older adults. In: Neurology, 2003, vol. 60, no.12, p.1899-1903.

International Diabetes Federation. The IDF Consensus Worldwide Definition of the Metabolic Syndrome. In: IDF, 2006. 24 p.

Diagnosis and Management of the Metabolic Syndrome. In: Сirculation, 2005, vol.112.

ALBERTI, K.G., ECKEL, R.H., GRUNDY, S.M. et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention. In: Circulation, 2009, vol.120, no.16, p.1640-1645.

BAI, Y.M., CHEN, J.Y., YANG, W.S. et al. Adiponectin as a potential biomarker for the metabolic syndrome in Chinese patients taking clozapine for schizophrenia. In: J.Clin.Psychiatry, 2007, vol.68, no.12, p.1834-1839.

ЛЕВИН, О.С. Эффективность Ноопепта при дисциркуляторной гипертонической энцефалопатии. B: Пожилой пациент, 2016, №1(4), c.30-35.

ПЯТНИЦКИЙ, Н.Ю. Сравнительная характеристика психических расстройств при разных видах эндокрино¬патий. B: Социальная и клиническая психиатрия, 2001, том 11, №4, с.10-13.

PANZA, F., FRISARDI, V., CAPURSO, C. et al. Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms. In: J. Alzheimers Dis., 2010, vol.21, no.3, p.691-724.

АЛЕКСЕЕВА, Н.С. Влияние компонентов метаболического синдрома на качество жизни пациентов. B: Журнал Acta Biomedica Scientifica, 2014. – https://cyberleninka.ru/article.

ГАНЧАР, Е.П., КАЖИНА, М.В. Уровень свободных аминокислот и их производных в плазме крови у женщин репродуктивного возраста, страдающих метаболическим синдромом. B: Журнал Гродненского государст¬венного медицинского университета, 2014. – https://cyberleninka.ru/article.

СИМОНОВА, Г.И., ПЕЧЕНКИНА, Е.А., ЩЕРБАКОВА, Л.В., НИКИТИН, Ю.П. Распространенность метବбо¬-лического синдрома и его компонентов в Сибири. B: Тезисы докладов конференции «Актуальные вопросы диагностики и лечения метаболического синдрома», Москва, 2006, c.17.

KUMARI, M., MARMOT, M. Diabetes and cognitive function in a middle-aged cohort: findings from the Whitehall II study. In: Neurology, 2005, vol.65, no.10, p.1597-1603.

MUNIYAPPA, R., IANTORNO, M., QUON, M.J. An integrated view of insulin resistance and endothelial dysfunction. In: Endocrinol. Metab. Clin. North Am., 2008, vol.37, no.3, p.685-711.

ROSMOND, R. Role of stress in the pathogenesis of the metabolic syndrome. In: Psychoneuroendocrinology, 2005, no.30(1), p.1-10.

SCHRIJVERS, E.M., WITTEMAN, J.C., SIJBRANDS, E.J. et al. Insulin metabolism and the risk of Alzheimer disease: the Rotterdam Study. In: Neurology, 2010, vol.75, no.22, p.1982-1987.

World Health Organization. Definition, Diagnosis and Classification of Diabetes Melitus and Its Complications. Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. World Health Organization, 1999. 66 p.

ЧАЗОВА, Е.И., МЫЧКА, В.Б. Метаболический синдром. B: Consilium Medicum, 2002, no.11.

FAROOQUI, T., FAROOQUI, A. Metabolic syndrome and neurological diseases, 2013.

АМЕТОВ, А.С. Сахарный диабет 2 типа. Основы патогенеза и терапии. Москва, 2003.

BOELLO, O., ZAMBONI, M. Visceral obesity and metabolic syndrome. In: Obesrev, 2000, p.47-56.

BALDELLIR, DIEGUEZ, C, CASANUEVA, F.F. The role of leptin in reproduction: experimental and clinical aspects. In: Ann. Med., 2002, vol.34, p.5-18.

ЧАЗОВА, И.Е., МЫЧКА, В.Б. Метаболический синдром. Москва, 2004, с.22.

ШЕСТАКОВА, М.В., БРЕСКИНА, О.Ю. Акарбоза в профилактике сахарного диабета типа 2. В: Сахарный диабет, 2003, №2, с.38-42.

ХАУСТОВА, Е.А. Психосоматический подход к болезням цивилизации (на примере метаболического синдрома Х). В: Газета «Новости медицины и фармации». Неврология и психиатрия, 2008, (243). УНИИ ССПН, г. Киев.

REAVEN, G.M. Role of insulin resistance in human disease (syndrome X): an expanded definition. In: Annu. Rev. Med., 1993, vol.41, p.121-131.

МАНЬКОВСКИЙ, Б.Н. Метаболический синдром: распространенность, диагностика, принципы терапии. B: Мистецтво лікування, 2005, №9, c.30-33.

AWAD, N., GAGNON, M., MESSIER, C. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. In: J. Clin. Exp. Neuropsychol., 2004, vol.26, no.8, p.1044-1080.

BIESSELS, G.J., STAEKENBORG, S., BRUNNER, E. et al. Risk of dementia in diabetes mellitus: a systematic review. In: Lancet Neurol., 2006, vol.5, no.1, p.64-74.

CONVIT, A., WOLF, O.T., TARSHISH, C., DE LEON, M.J. Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly. In: Proc. Natl. Acad. Sci. USA, 2003, vol.100, no.4, p.2019-2022.

CRAFT, S. The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. In: Arch. Neurol., 2009, vol.66, no.3, p.300-305.

GOLD, S.M., DZIOBEK, I., SWEAT, V. et al. Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. In: Diabetologia, 2007, vol.50, no.4, p.711-719.

JEONG, S.K., NAM, H.S., SON, M.H. et al. Interactive effect of obesity indexes on cognition. In: Dement. Geriatr. Cogn. Disord., 2005, vol.19, no.2-3, p.91-96.

KORF, E.S., VAN STRAATEN, E.C., DE LEEUW, F.E. et al. Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study. In: Diabet. Med., 2007, vol.4, no.2, p.166-171.

LUBEC, С., ROSENTAL, N.Y. Amino Acids. Escom, 1990. 1196 p.

ШЕСТАКОВА М.В. Дисфункция эндотелия – причина или следствие метаболического синдрома? B: Рос. мед. журн., 2001, том 9, №2, с.88-90.

GIANNOPOULOS, S., BODEN-ALBALA, B., CHOI, J.H. et al. Metabolic syndrome and cerebral vasomotor reactivity. In: Eur. J. Neurol., 2010, vol.17, no.12, p.1457-1462.

HANSEN, T., INGASON, A., DJUROVIC, S. et al. At-risk variant in TCF7L2 for type II diabetes increases risk of schizophrenia. In: Biol. Psychiatry, 2011, vol.1, no.70, p.59-63.

YAFFE, K., KANAYA, A., LINDQUIST K. et al. The metabolic syndrome, inflammation, and risk of cognitive decline. In: JAMA, 2004, vol.292, no.18, p.2237-2242.

НАУГОЛЬНЫХ, Ю.В. Особенности психовегетативных нарушений у детей с метаболическим синдромом: Автореферат диссертации на соискание ученой степени кандидата медицинских наук. Специальность 14 00 13 – неврология, 14 00 03 – эндокринология. Пермь, 2007.

БЕРЕЗОВ, Т.Т. и др. Биологическая химия, 1998. 750 с.

БУТРОВА, С.А. Метаболический синдром: патогенез, клиника, диагностика, подходы к лечению. B: Медицинское обозрение (Mосква), 2018, №11.

ВЛАСЮК, Г.А. и др. Химические элементы и аминокислоты в жизни растений, животных и человека. Киев, 1974. 287 с.


Refbacks

  • There are currently no refbacks.